Inverness Medical Innovations Announces Third Quarter 20...(nine months ended September 30 2008 were...),Health

           Inverness Medical Innovations, Inc. and Subsidiaries
           Condensed Consolidated Statements of Operations and
          Reconciliation to Non-GAAP Adjusted Cash Basis Amounts
                     (in $000s, except per share amounts)


                    Three Months Ended September 30, 2009
                                                                Non-GAAP
                                                                Adjusted
                                      Non-GAAP                    Cash
                              GAAP  Adjustments                 Basis (a)

    Net product sales
     and services revenue   $527,962        $-                  $527,962
    License and royalty        7,848         -                     7,848
      revenue
        Net revenue          535,810         -                   535,810
    Cost of net revenue      252,842   (14,084)(b)(c)(d)(e)      238,758
        Gross profit         282,968    14,084                   297,052
        Gross margin              53%                                 55%

    Operating expenses:
        Research and
         development          27,720    (2,462)(b)(c)(d)          25,258
        Selling, general
         and administrative  204,642   (67,325)(b)(c)(d)(f)      137,317
        Gain on disposition   (3,355)    3,355(g)                      -
         Operating income     53,961    80,516                   134,477
    Interest and other
     income (expense), net   (29,625)     (504)(c)(h)(i)(j)      (30,129)
    Income tax provision
     (benefit)                 6,253    28,818(k)                 35,071
      Equity earnings of
       unconsolidated entities,
       net of tax              2,059     1,139(b)(c)               3,198

        Net income (loss)    $20,1
'/>"/>
SOURCE  Inverness Medical Innovations, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 
Related medicine technology :

1. Blanchette Rockefeller Neurosciences Institute and Inverness Medical Innovations to Develop Commercial Test to Detect Early Alzheimers Disease
2. Inverness Medical Innovations Participates in Meeting on HIV/AIDS with UN Secretary-General
3. Inverness Medical Innovations Receives USDA Licensure of the BinaxNOW(R) Avian Influenza Virus Type A Antigen Test Kit
4. Inverness Medical Innovations to Present at CIBC World Markets 18th Annual Healthcare Conference on November 7, 2007
5. StatSure Signs Strategic Financing and License Deals with Inverness Medical Innovations
6. Medical Food Reduces Medical Costs and Use of Anticonvulsant Medication When Treating Diabetic Neuropathy, According to HealthCore Study Presented at ISPOR
7. Reportlinker Adds Medical Devices & Equipment in India (2009)
8. ATS Medical Announces Third Quarter 2009 Earnings Release Date and Conference Call
9. Rcadia Medical Imaging Wins 2009 AuntMinnie.com Best New Radiology Vendor Award
10. Cardio Vascular Medical Device Sends Update to Shareholders
11. Symmetry Medical Updates Full Year 2009 Financial Guidance